1
|
Micas Pedersen S, Hersby DS, Jarden M, Nielsen TH, Gang AO, Poulsen CB, de Nully Brown P, Jørgensen N, Feltoft CL, Pedersen LM. Sexual health and testosterone concentration in male lymphoma survivors: A systematic review. Heliyon 2024; 10:e31915. [PMID: 38961916 PMCID: PMC11219276 DOI: 10.1016/j.heliyon.2024.e31915] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2023] [Revised: 05/21/2024] [Accepted: 05/23/2024] [Indexed: 07/05/2024] Open
Abstract
Advancements in lymphoma treatment have increased the number of long-term survivors who may experience late effects such as impaired sexual function and testosterone deficiency. The aim of this review was to determine the prevalence of testosterone deficiency and sexual dysfunction among male lymphoma survivors; and associations between the two. A systematic search identified 20 articles for inclusion. The prevalence of low total testosterone was 0%-50 %, with mean values within reference levels, and for luteinizing hormone above reference levels in 0%-80 %. Four studies included SHBG and free testosterone, with mixed results. Compromised sexual health was found in 23%-61 %. Overall, total testosterone and sexual health were associated. The risk of bias (ROBINS-E and RoB 2) was high/very high, leading to low/very low overall confidence in the bulk of evidence (GRADE). Longitudinal studies evaluating biologically active testosterone and sexual health are needed, to develop evidence based standard procedures for follow-up of sexual health.
Collapse
Affiliation(s)
- Signe Micas Pedersen
- Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Blegdamsvej 9, 2100, KBH Ø, Denmark
- Department of Oncology, Copenhagen University Hospital – Herlev and Gentofte, Borgmester Ib Juuls Vej 1, 2730, Herlev, Denmark
| | - Ditte Stampe Hersby
- Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Blegdamsvej 9, 2100, KBH Ø, Denmark
| | - Mary Jarden
- Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Blegdamsvej 9, 2100, KBH Ø, Denmark
- Department of Clinical Medicine, University of Copenhagen, Blegdamsvej 3B, 2200 KBH N, Denmark
| | - Torsten Holm Nielsen
- Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Blegdamsvej 9, 2100, KBH Ø, Denmark
- Danish Medicines Agency, Axel Heides Gade 1, 2300, KBH S, Denmark
| | - Anne Ortved Gang
- Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Blegdamsvej 9, 2100, KBH Ø, Denmark
- Department of Clinical Medicine, University of Copenhagen, Blegdamsvej 3B, 2200 KBH N, Denmark
| | - Christian Bjørn Poulsen
- Department of Hematology, Zealand University Hospital, Vestermarksvej 15, 4000, Roskilde, Denmark
| | - Peter de Nully Brown
- Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Blegdamsvej 9, 2100, KBH Ø, Denmark
| | - Niels Jørgensen
- Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Blegdamsvej 9, 2100, KBH Ø, Denmark
| | - Claus Larsen Feltoft
- Department of Endocrinology, Copenhagen University Hospital – Herlev and Gentofte, Borgmester Ib Juuls Vej 1, 2730, Herlev, Denmark
| | - Lars Møller Pedersen
- Department of Clinical Medicine, University of Copenhagen, Blegdamsvej 3B, 2200 KBH N, Denmark
- Department of Hematology, Zealand University Hospital, Vestermarksvej 15, 4000, Roskilde, Denmark
| |
Collapse
|
2
|
Hammond N, Chantry A, Cheeseman M, Peng A. Disrupted biographies and gendered identities: A qualitative study exploring sexuality and blood cancer. Eur J Oncol Nurs 2024; 70:102544. [PMID: 38513454 DOI: 10.1016/j.ejon.2024.102544] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2022] [Revised: 01/24/2024] [Accepted: 02/25/2024] [Indexed: 03/23/2024]
Abstract
PURPOSE This study examines how blood cancer impacts patients' sexuality and sense of gendered identity. METHODS An interpretive epistemological framework necessitated a qualitative study design. Participants (6 male and 6 female), recruited from a hospital Haematology department in a large Northern English City, took part in semi-structured in-depth interviews to gather rich data about their subjective experiences. RESULTS A key theme from the qualitative data was a sense of disruption in relation to several aspects of their gendered identities and sexual life. Participants explained disruption to their sexual function and sexual sense of self. They narrated concerns about future imagined relationships. The emotional burden of sexuality related concerns was strongly articulated. A gendered perspective enabled the similarities and differences between men and women to be explored. CONCLUSION This study, drawing on rich qualitative data, documents the sexuality concerns of blood cancer patients; for some such concerns arise many years post treatment. The findings highlight the need for gender appropriate care around sexuality which should continue to be accessible well after diagnosis and treatment phases have ceased.
Collapse
|
3
|
Booker R, Walker L, Raffin Bouchal S. Sexuality after hematopoietic stem cell transplantation: A mixed methods study. Eur J Oncol Nurs 2019; 39:10-20. [PMID: 30850133 DOI: 10.1016/j.ejon.2019.01.001] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2018] [Revised: 12/20/2018] [Accepted: 01/03/2019] [Indexed: 02/06/2023]
Abstract
PURPOSE This study examined patients' experiences of sexuality following hematopoietic stem cell transplantation. A secondary aim of the study was to explore healthcare provider-patient communication about sexuality. METHODS A mixed methods design was employed with an embedded qualitative-quantitative approach whereby the quantitative data were used to supplement the qualitative results. Participants (8 male and 3 female) participated in semi-structured interviews and also completed the FACT-BMT questionnaire. RESULTS Qualitative themes that emerged included: changes in sexual function (such as with desire and arousal), changes in relation to self (such as with body image, sexual identity), changes in relation to others (such as with current relationships, starting new relationships, fear of exposure to 'germs') and the experience of discussing sexual health concerns with healthcare providers. Quantitative data from the FACT-BMT revealed that participants reported low satisfaction with their sex life but remained interested in sex. The majority of participants reported dissatisfaction with the appearance of their body and most were not concerned about fertility. CONCLUSION This study documents the physical and psychosocial sexual health concerns reported in male and female recipients of HSCT. Concerns were present even for those many years post-HSCT. Implications include suggestions for healthcare providers regarding patient education and assessment of sexual health changes in patients throughout the HSCT trajectory and continuing well into survivorship.
Collapse
Affiliation(s)
- Reanne Booker
- Department of Psychosocial Resources, Tom Baker Cancer Centre, 1331 29 Street NW, Calgary, Alberta, T2N 4N2, Canada.
| | - Lauren Walker
- Department of Psychosocial Resources, Tom Baker Cancer Centre, 1331 29 Street NW, Calgary, Alberta, T2N 4N2, Canada; Department of Oncology, Division of Psychosocial Oncology, University of Calgary, 1331 29 Street NW, Calgary, Alberta, T2N 4N2, Canada.
| | - Shelley Raffin Bouchal
- Department of Graduate Studies, Faculty of Nursing, 2800 University Way NW, University of Calgary, Calgary, Alberta, T2N 1N4, Canada.
| |
Collapse
|
4
|
Sexual health in patients with hematological malignancies: a neglected issue. Support Care Cancer 2018; 26:1699-1701. [PMID: 29502153 DOI: 10.1007/s00520-018-4124-2] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2017] [Accepted: 02/20/2018] [Indexed: 11/12/2022]
Abstract
Current evidence, although limited, outlines that sexual dysfunction may represent a prominent part of the symptom burden experienced by the patients with hematologic malignancies (HM). However, despite their presumed negative effects on quality of life (QoL), sexual health is not typically considered in the QoL assessment of HM patients. In addition, very few studies have been conducted in this area. Therefore, it would be important to further investigate how newer drugs developed in recent years for patients with HM, including targeted therapies and impact on sexual health, and how this influence overall patients' QoL outcomes.
Collapse
|
5
|
Zhou ES, Nekhlyudov L, Bober SL. The primary health care physician and the cancer patient: tips and strategies for managing sexual health. Transl Androl Urol 2016; 4:218-31. [PMID: 26816826 PMCID: PMC4708119 DOI: 10.3978/j.issn.2223-4683.2014.11.07] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
There is a large and growing population of long-term cancer survivors. Primary care physicians (PCPs) are playing an increasingly greater role in the care of these patients across the continuum of cancer survivorship. In this role, PCPs are faced with the responsibility of managing a range of medical and psychosocial late effects of cancer treatment. In particular, the sexual side effects of treatment which are common and have significant impact on quality of life for the cancer survivor, often go unaddressed. This is an area of clinical care and research that has received increasing attention, highlighted by the presentation of this special issue on Cancer and Sexual Health. The aims of this review are 3-fold. First, we seek to overview common presentations of sexual dysfunction related to major cancer diagnoses in order to give the PCP a sense of the medical issues that the survivor may present with. Barriers to communication about sexual health issues between patient/PCPs in order are also described in order to emphasize the importance of PCPs initiating this important conversation. Next, we provide strategies and resources to help guide the PCP in the management of sexual dysfunction in cancer survivors. Finally, we discuss case examples of survivorship sexual health issues and highlight the role that a PCP can play in each of these case examples.
Collapse
Affiliation(s)
- Eric S Zhou
- 1 Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA ; 2 Harvard Vanguard Medical Associates, Boston, Massachusetts, USA
| | - Larissa Nekhlyudov
- 1 Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA ; 2 Harvard Vanguard Medical Associates, Boston, Massachusetts, USA
| | - Sharon L Bober
- 1 Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA ; 2 Harvard Vanguard Medical Associates, Boston, Massachusetts, USA
| |
Collapse
|
6
|
Li Z, Mewawalla P, Stratton P, Yong ASM, Shaw BE, Hashmi S, Jagasia M, Mohty M, Majhail NS, Savani BN, Rovó A. Sexual health in hematopoietic stem cell transplant recipients. Cancer 2015; 121:4124-31. [PMID: 26372459 DOI: 10.1002/cncr.29675] [Citation(s) in RCA: 41] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2015] [Revised: 08/02/2015] [Accepted: 08/10/2015] [Indexed: 01/22/2023]
Abstract
Hematopoietic stem cell transplantation (HSCT) plays a central role in patients with malignant and, increasingly, nonmalignant conditions. As the number of transplants increases and the survival rate improves, long-term complications are important to recognize and treat to maintain quality of life. Sexual dysfunction is a commonly described but relatively often underestimated complication after HSCT. Conditioning regimens, generalized or genital graft-versus-host disease, medications, and cardiovascular complications as well as psychosocial problems are known to contribute significantly to physical and psychological sexual dysfunction. Moreover, it is often a difficult topic for patients, their significant others, and health care providers to discuss. Early recognition and management of sexual dysfunction after HSCT can lead to improved quality of life and outcomes for patients and their partners. This review focuses on the risk factors for and treatment of sexual dysfunction after transplantation and provides guidance concerning how to approach and manage a patient with sexual dysfunction after HSCT.
Collapse
Affiliation(s)
- Zhuoyan Li
- Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Prerna Mewawalla
- Department of Hematology, Western Pennsylvania Cancer Institute, Pittsburgh, Pennsylvania
| | - Pamela Stratton
- Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland
| | - Agnes S M Yong
- Department of Haematology, SA Pathology, and School of Medicine, University of Adelaide, Adelaide, South Australia, Australia
| | - Bronwen E Shaw
- Center for International Blood and Marrow Transplant Research, Froedtert and the Medical College of Wisconsin, Milwaukee, Wisconsin
| | | | - Madan Jagasia
- Hematology and Stem Cell Transplantation Section, Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center and Veterans Affairs Medical Center, Nashville, Tennessee
| | - Mohamad Mohty
- INSERM (National Institute of Health and Medical Research) 938, Paris, France
| | - Navneet S Majhail
- Blood and Marrow Transplant Program, Cleveland Clinic, Cleveland, Ohio
| | - Bipin N Savani
- Hematology and Stem Cell Transplantation Section, Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center and Veterans Affairs Medical Center, Nashville, Tennessee
| | - Alicia Rovó
- Department of Hematology, University Hospital of Bern, Bern, Switzerland
| |
Collapse
|
7
|
|